S. Duan

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Su X Duan, S.x. Duan, S. X. Duan, S X Duan, Sumei Duan, Su X. Duan, Su Xiang Duan
Publication record
40 papers · 4,552 citations · H-index 32

PAPERS

Mechanism of dasabuvir inhibition of acetaminophen glucuronidation.
20214 citationsauthor #2
Effect of lipophilicity on drug distribution and elimination: Influence of obesity
202161 citationsauthor #3
Directive function of intracavitary electrocardiogram bimodal P-wave in the position of PICC tip
20192 citationsauthor #3
Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers
201752 citationsauthor #4
The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure
201378 citationsauthor #7
Mechanism of cytochrome P450‐3A inhibition by ketoconazole
2011107 citationsauthor #4
Role of CYP3A and CYP2E1 in Alcohol-Mediated Increases in Acetaminophen Hepatotoxicity: Comparison of Wild-Type and Cyp2e1(–/–) Mice
200766 citationsauthor #8
ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO
2005136 citationsauthor #2
Synthesis and evaluation of hydrolyzable hyaluronan-tethered bupivacaine delivery systems.
200523 citationsauthor #5
ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
200546 citationsauthor #7
Serotonin (5-hydroxytryptamine) glucuronidation in vitro : assay development, human liver microsome activities and species differences
200353 citationsauthor #2
Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
2003264 citationsauthor #4
Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6.
2003119 citationsauthor #2
Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9.
2002189 citationsauthor #2
Cytochrome P-450 2B6 Is Responsible for Interindividual Variability of Propofol Hydroxylation by Human Liver Microsomes
2001216 citationsauthor #2
Inhibition of Human Cytochrome P450 Isoforms by Nonnucleoside Reverse Transcriptase Inhibitors
2001122 citationsauthor #5
Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.
2001311 citationsauthor #2
Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole
200097 citationsauthor #3
Cytochrome P-450 2 B 6 Is Responsible for Interindividual Variability of Propofol Hydroxylation by Human Liver Microsomes
200016 citationsauthor #2
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
2000422 citationsauthor #5
Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations.
1999137 citationsauthor #4
Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects.
199991 citationsauthor #12
Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects.
199991 citationsauthor #11
Kinetic Characterization and Identification of the Enzymes Responsible for the Hepatic Biotransformation of Adinazolam and N‐Desmethyladinazolam in Man
199850 citationsauthor #3
Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermine.
199812 citationsauthor #6
Inhibition of triazolam clearance by macrolide antimicrobial agents: In vitro correlates and dynamic consequences
199894 citationsauthor #8
Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir
1998271 citationsauthor #5
Inhibition of Triazolam Hydroxylation by Ketoconazole, Itraconazole, Hydroxyitraconazole and Fluconazole In‐vitro
199825 citationsauthor #3
Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo.
199881 citationsauthor #3
Venlafaxine and metabolites are very weak inhibitors of human cytochrome P450-3A isoforms.
199728 citationsauthor #2
Human cytochromes mediating N-demethylation of fluoxetine in vitro
199783 citationsauthor #3
Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies.
199653 citationsauthor #5
Midazolam Hydroxylation by Human Liver Microsomes In Vitro: Inhibition by Fluoxetine, Norfluoxetine, and by Azole Antifungal Agents
1996231 citationsauthor #4
Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine
1996113 citationsauthor #3
Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo.
199685 citationsauthor #3
In vitro biotransformation of phenacetin to acetaminophen: Metabolic inhibition by antidepressants
19961 citationsauthor #3
Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.
1996247 citationsauthor #4
Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants.
1995185 citationsauthor #4
Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
1994176 citationsauthor #4
In Vitro Prediction of the Terfenadine‐Ketoconazole Pharmacokinetic Interaction
1994116 citationsauthor #3

TIMELINE

1994 292 citations

1995 185 citations

1996 730 citations

1997 111 citations

1998 533 citations

1999 228 citations

2000 535 citations

2001 649 citations

2002 189 citations

2003 436 citations

2005 205 citations

2007 66 citations

2011 107 citations

2013 78 citations

2017 52 citations

2019 2 citations

2021 65 citations

S. Duan

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT